Skip to main content
OpenTrials
Completed

NCT Number: NCT04402996

Meteorin-like Levels in Individuals With Periodontitis

Metrnl has proven to be an inflammatory-related immunoregulatory cytokine and shown to play a role in the pathogenesis of human inflammatory diseases. Metrnl is highly expressed from the oral mucosa to the esophagus. Periodontitis is a chronic inflammatory disease that can start with localized inflammatory reactions created by the supporting tissues surrounding the teeth against microorganisms and then result in loss of teeth. The authors think that Metrnl may play a role in the periodontitis. The aim of this study is to compare the Metrnl, IL-1β, and IL-10 levels of healthy and periodontitis individuals.

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year–70 year

Sex eligibility

All sexes

Study type

Observational

Primary location

Ebru Sağlam

Istanbul, Eyalet/Yerleşke, 34668, Turkey (Türkiye)

About this study

Periodontitis is a destructive chronic inflammatory disease that can start with localized inflammatory reactions created by the supporting tissues surrounding the teeth against microorganisms and then result in loss of teeth. Cytokines play an important role in inflammation that occurs in periodontal disease.

Interleukine -1β ( IL-1β ) levels are associated with periodontal destruction in the pathogenesis of periodontal disease. Cytokines such as Interleukine-10 (IL-10) and transforming growth factor- β (TGF-β) have been reported to decrease periodontal disease progression rate.

Gingival crevicular fluid shows the cellular response in the periodontium. The most important host-related ingredients are inflammatory markers, including cytokines, enzymes, and interleukins. Saliva analysis is used in the diagnosis of systemic conditions as well as in the diagnosis of oral pathologies.

Meteorin- like (Metrnl) is a protein that plays a role in natural and acquired immune-related functions and inflammatory responses, and expressed in barrier tissues (skin and mucosa) as well as various macrophage populations, from dendritic cells and some granulocytes. Metrnl has proven to be an inflammatory-related immunoregulatory cytokine and shown to play a role in the pathogenesis of human inflammatory diseases. Metrnl, which is highly expressed from the oral mucosa to the esophagus, may play a role in the onset of periodontitis and an effective marker in preventing the progression of destruction. We think that Metrnl plays an important role in periodontitis, an inflammatory disease. The aim of this study is to compare the Metrnl, IL-1β, and IL-10 levels of healthy and periodontitis individuals

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • systemically healthy
  • individuals who does not have a disease under treatment,
  • individuals without regular systemic medication

Exclusion criteria

  • smoking
  • receiving periodontal treatment in the last 6 months
  • pregnancy
  • menopausal or menstrual period

Treatment and study plan

saliva

Other

individuals' saliva samples will be collected and transferred to eppendorf tubes.

Until biochemical analysis is carried out will be stored in -80ºC.

Other names: sampling

Gingival Crevicular Fluid

Other

GCF samples of individuals will be collected by paper strips and transferred to eppendorf tubes.

Until biochemical analysis is carried out will be stored in -80ºC.

Other names: sampling

Primary outcomes

  1. IL-1β

    Time frame: through study completion, an average of 6 months

    saliva and serum levels

  2. Metrnl

    Time frame: through study completion, an average of 6 months

    saliva and serum levels

  3. IL-10 levels

    Time frame: through study completion, an average of 6 months

    saliva and serum levels

Secondary outcomes

  1. Plaque Index

    Time frame: up to 20 weeks

    Silness-Löe

  2. Probing Depth

    Time frame: up to 20 weeks

    millimeter

  3. Bleeding on Probe

    Time frame: up to 20 weeks

    Ainamo&Bay

Sponsors and collaborators

Lead sponsor

Istanbul Saglik Bilimleri University

Other

Registry information

Official study title

Evaluation of Meteorin-like Levels in Individuals With Healthy and Periodontal Disease

Important dates

Study start
2020
Primary completion
2021
Study completion
2021
First posted
May 27, 2020
Registry last updated
Apr 29, 2024

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.